DRAXIS RADIOPHARMACEUTICALS DIVISION UPDATES PRODUCT RESEARCH AND DEVELOPMENT STRATEGY
Draximage, the radiopharmaceutical division of Draxis Health Inc., has realigned its priorities for the research and development of new products that will drive future growth. Priorities for product development were established based on several factors,
including time to market, customer needs, size of target markets, cost of development
and expected regulatory challenges for the various opportunities.